Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Accelerate Diagnostics, Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 84 | 2 | 73 | −9 |
| Shares | 27.1M | 223.4K | 25.5M | −1.34M (−5.0%) |
| Value | $41.2M | $339.0K | $18.0M | −$22.8M (−56.0%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Accelerate Diagnostics, Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tejara Capital Ltd | 262,631 | $185.4K | 0.11% |
| Acadian Asset Management LLC | 81,285 | $57.0K | 0.00% |
| Destiny Capital Corp | 38,310 | $25.3K | 0.02% |
| HRT Financial LP | 12,931 | $9.00K | 0.00% |
| CI Private Wealth, LLC | 12,500 | $8.82K | 0.00% |
| Greenwich Wealth Management LLC | 10,800 | $8.00K | 0.00% |
Sold out (15)
Institutions that held Accelerate Diagnostics, Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| 1492 Capital Management LLC | 449,746 | $684.0K |
| Driehaus Capital Management LLC | 300,000 | $456.0K |
| Calamos Advisors LLC | 174,487 | $266.0K |
| Allworth Financial LP | 154,000 | $234.0K |
| Russell Investments Group, Ltd. | 136,584 | $207.0K |
| Jane Street Group, LLC | 48,615 | $73.0K |
| XTX Topco Ltd | 31,176 | $47.0K |
| Chicago Capital, LLC | 20,000 | $30.0K |
| Cubist Systematic Strategies, LLC | 18,768 | $29.0K |
| Qube Research & Technologies Ltd | 16,871 | $26.0K |
| Two Sigma Securities, LLC | 15,128 | $23.0K |
| LMR Partners LLP | 11,766 | $18.0K |
| Running Point Capital Advisors, LLC | 10,000 | $15.0K |
| FMR LLC | 3,006 | $5.00K |
| Capital Advisors, Ltd. LLC | 1,531 | $2.00K |
Not filed for Q4 2022 yet (2)
Institutions that held Accelerate Diagnostics, Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eaton Vance Management | 223,215 | $339.0K |
| Covington Capital Management | 175 | $0 |